Replies to post #141049 on PharmaCyte Biotech Inc (PMCB)

[DragonBear]

At $1 I will have $16,400,000-and at 0.0001?

What large pharma is going to pay $2.5B (or $3.5B after future dilution, for a pile of worthless stock certificates? An IND on permanent Hold. No pipeline. No revenues. Not much of anything.

The reader is invited to compare recent acquisitions in the $2.5-3.5B range. What was being bought per various drugs in the pipeline? How far along were the various drugs in clinical testing? The projected potential revenue/market share if approved? The O/S for those companies? One will find they don't involve Microcrap scams with nothing to offer.